EPLIN Expression in Gastric Cancer and Impact on Prognosis and Chemoresistance

Epithelial protein lost in neoplasm (EPLIN) has been implicated as a suppressor of cancer progression. The current study explored EPLIN expression in clinical gastric cancer and its association with chemotherapy resistance. EPLIN transcript expression, in conjunction with patient clinicopathological...

Descripción completa

Detalles Bibliográficos
Autores principales: Gong, Wenjing, Zeng, Jianyuan, Ji, Jiafu, Jia, Yongning, Jia, Shuqin, Sanders, Andrew J., Jiang, Wen G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068319/
https://www.ncbi.nlm.nih.gov/pubmed/33917939
http://dx.doi.org/10.3390/biom11040547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068319/
https://www.ncbi.nlm.nih.gov/pubmed/33917939
http://dx.doi.org/10.3390/biom11040547

Ejemplares similares